Related Experiment Videos
Liposoluble platinum(II) complexes with antitumor activity.
Japanese Journal of Cancer Research : Gann
|June 1, 1986
Summary
New platinum(II) complexes with cyclohexane-1,2-diammine ligands showed excellent antitumor activity against leukemia L1210 cells. These liposoluble compounds, when delivered via lipiodol, demonstrated efficacy without host toxicity, unlike simpler platinum complexes.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Materials Science
Background:
- Platinum-based drugs are crucial in cancer chemotherapy.
- Developing novel platinum complexes with improved efficacy and reduced toxicity is an ongoing research area.
- Liposomal and lipid-based drug delivery systems offer potential for targeted cancer therapy.
Purpose of the Study:
- To synthesize and evaluate novel liposoluble platinum(II) complexes for antitumor activity.
- To investigate the influence of ligand structure and carrier solvent on drug efficacy and toxicity.
- To assess the in vitro release kinetics of the synthesized platinum complexes.
Main Methods:
- Synthesis of seventeen platinum(II) complexes, including bis(carboxylato)-cyclohexane-1,2-diammineplatinum(II) and bis(carboxylato)-cis-diammineplatinum(II) derivatives.
- In vivo antitumor activity testing against leukemia L1210 cells in mice.
- In vitro release studies using lipiodol as a carrier solvent and saline as the release medium.
- Toxicity assessment in host mice at therapeutic doses.
Main Results:
- Bis(carboxylato)-cyclohexane-1,2-diammineplatinum(II) complexes exhibited excellent antitumor activity against leukemia L1210 cells.
- These active complexes showed no host toxicity at therapeutic doses when formulated with lipiodol.
- Bis(carboxylato)-cis-diammineplatinum(II) complexes displayed neither antitumor activity nor toxicity.
- In vitro studies confirmed gradual release of active complexes from lipiodol, correlating with their in vivo performance.
- Antitumor efficacy was dependent on the carboxylato residue chain length and ligand molecular shape.
Conclusions:
- Liposoluble bis(carboxylato)-cyclohexane-1,2-diammineplatinum(II) complexes represent promising candidates for leukemia treatment.
- Lipiodol serves as an effective carrier solvent, enhancing the therapeutic index of these platinum complexes.
- Rational design of platinum ligands is critical for developing potent and safe anticancer agents.